BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2433859)

  • 1. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
    Cierniewski CS; Janiak A; Wyroba E
    Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of anti-beta 43-47 Fab fragments on expression of the polymerization sites in the E domain of fibrinogen.
    Cierniewski CS; Poniatowski J
    Acta Biochim Pol; 1990; 37(1):31-7. PubMed ID: 2087914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an antifibrin monoclonal antibody and fragments thereof on some properties of fibrin.
    Wasser MN; Welling M; Lamers G; Pauwels EK; Nieuwenhuizen W
    Thromb Haemost; 1990 Feb; 63(1):39-43. PubMed ID: 2111047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Dec; 56(6):1509-18. PubMed ID: 53241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of fibrin polymerization with monoclonal antibodies.
    Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
    Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS; Kloczewiak M; Budzynski AZ
    J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies specific for a conformationally altered state of fibrinogen.
    Zamarron C; Ginsberg MH; Plow EF
    Thromb Haemost; 1990 Aug; 64(1):41-6. PubMed ID: 1703332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin formation: the role of the fibrinogen-fibrin monomer complex.
    Brass EP; Forman WB; Edwards RV; Lindan O
    Thromb Haemost; 1976 Aug; 36(1):37-48. PubMed ID: 1036827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular localization of the ability of certain monoclonal immunoglobulins to interfere with fibrin polymerization.
    Wisløff F; Michaelsen TE; Kierulf P; Godal HC
    Thromb Res; 1985 Nov; 40(4):473-82. PubMed ID: 4082120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Properties of 2 fibrin monomer forms which differ in the degree of thrombin activation. Relation of these 2 forms to specific polymerization inhibitors].
    Lugovskoi EV; Tsariuk LA; Gogolinskaia GK; Derzskaia SG; Belitser VA
    Biokhimiia; 1978 Jul; 43(7):1162-6. PubMed ID: 698303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
    Siebenlist KR; Mosesson MW; Di Orio JP; Tavori S; Tatarsky I; Rimon A
    Thromb Haemost; 1989 Nov; 62(3):875-9. PubMed ID: 2512677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of an inhibitor of the thrombin-fibrinogen reaction localized in rat liver microsomes. Interference with the polymerization step.
    Helgeland L
    Thromb Haemost; 1976 Dec; 36(3):509-16. PubMed ID: 1037148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.
    Tollefsen DM; Majerus PW
    J Clin Invest; 1975 Jun; 55(6):1259-68. PubMed ID: 1169259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Equilibrium system consisting of soluble forms of fibrin and the specific anticoagulant D fragment of the firbinogen molecule].
    Smekhova KO; Ugarova TP; Pozdniakova TM; Belitser VO
    Ukr Biokhim Zh; 1977; 49(6):5-11. PubMed ID: 22149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of phosphatidyl serine with fibrin monomer].
    Mukhacheva IA; Byshevskiĭ ASh
    Biokhimiia; 1979 Nov; 44(11):1944-51. PubMed ID: 161862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of monoclonal antibodies for research on fibrin polymerization processes].
    Lugovskoĭ EV; Makogonenko EM; Chudnovets VS; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Liashko ED; Komissarenko SV
    Dokl Akad Nauk SSSR; 1991; 318(1):224-7. PubMed ID: 1716547
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of a fibrin polymerization site.
    Olexa SA; Budzynski AZ
    J Biol Chem; 1981 Apr; 256(7):3544-9. PubMed ID: 6451630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.
    Scheraga HA
    Ann N Y Acad Sci; 1983 Jun; 408():330-43. PubMed ID: 6575693
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymerization site in the beta chain of fibrin: mapping of the B beta 1-55 sequence.
    Pandya BV; Gabriel JL; O'Brien J; Budzynski AZ
    Biochemistry; 1991 Jan; 30(1):162-8. PubMed ID: 1988018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.